MAPT and Alzheimer disease: Therefore, in the present study, we used P301S mice, a commonly used tauopathy model with several AD‐relevant features [22], to investigate whether hyperphosphorylated tau is associated with changes in the expression and subcellular localisation of the obligatory NMDAR subunit, GluN1, in the hippocampus.